11 Polen Capital Charles River Laboratories International Trades
Polen Capital acquired 4.25 Thousand Charles River Laboratories International shares worth $590 Thousand. That's 0.00% of their equity portfolio (115th largest holding). The first Charles River Laboratories International trade was made in Q2 2022. Since then Polen Capital bought shares three more times and sold shares on seven occasions. The investor's estimated purchase price is $983 Thousand, resulting in a loss of 40%.
News about Charles River Laboratories International Inc. and Polen Capital
Charles River Laboratories sells Avian Vaccine Services business to Arlington Capital
Charles River Laboratories (CRL) has sold its Avian Vaccine Services business to private equity firm Arlington Capital Partners.The business, now AVS Bio, wi...
Softlogic Finances Growth Trajectory Backed by Shareholder Confidence
Zero NPLs on Rs. 14 Billion worth loans in a globally challenging year Colombo, June 30, 2021 Softlogic Finance PLC, a subsidiary of Softlogic Capital the f...